NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases
- 11 May 2003
- journal article
- research article
- Published by Springer Nature in Nature Immunology
- Vol. 4 (6) , 565-572
- https://doi.org/10.1038/ni930
Abstract
In activated mouse natural killer (NK) cells, the NKG2D receptor associates with two intracellular adaptors, DAP10 and DAP12, which trigger phosphatidyl inositol 3 kinase (PI3K) and Syk family protein tyrosine kinases, respectively. Here we show that cytotoxicity, but not cytokine production, is triggered by NKG2D in activated NK cells lacking either DAP12 or the Syk family members Syk and ZAP70. Inhibition of PI3K blocks this cytotoxicity, suggesting that the DAP10-PI3K pathway is sufficient to initiate NKG2D-mediated killing of target cells. Our results highlight signaling divergence in the effector functions of NKG2D and indicate that alternative associations between a receptor and its adaptors may provide a single receptor with a dual 'on-switch', giving mouse NK cells more choices through which to trigger cytotoxicity.Keywords
This publication has 35 references indexed in Scilit:
- Impairment of NK Cell Function by NKG2D Modulation in NOD MiceImmunity, 2003
- Versatile signaling through NKG2DNature Immunology, 2002
- Natural killer cell activation in mice and men: different triggers for similar weapons?Nature Immunology, 2002
- The Role of the NKG2D Immunoreceptor in Immune Cell Activation and Natural KillingImmunity, 2002
- Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell ReceptorsScience, 2002
- Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICAScience, 1999
- REGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORSAnnual Review of Immunology, 1999
- NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate CytokinesAnnual Review of Immunology, 1999
- Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase SykNature, 1995
- Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategyNature, 1986